Can Injectable MDMA Become the Next Biohack in 2026? RFK Jr. vs FDA – Rick Doblin

Dave Asprey

Jun 12, 2025

Episode description

Psychedelic therapy is on the verge of reshaping mental health, trauma healing, and human consciousness. This episode reveals what’s really happening behind the scenes at the FDA, inside pharmaceutical companies, and within the global movement to legalize MDMA-assisted therapy. 



Watch this episode on YouTube for the full video experience: 

https://www.youtube.com/@DaveAspreyBPR 



Host Dave Asprey sits down with Rick Doblin, PhD, the legendary founder of MAPS and one of the most influential figures in psychedelic science. With nearly 40 years leading clinical research on MDMA, psilocybin, and trauma healing, Rick brings unmatched insight into how these compounds are transforming functional medicine, emotional resilience, and neuroplasticity. 



They break down the regulatory battle over MDMA therapy, the clash between pharmaceutical profit and public benefit, and the urgent need to combine pharmacology with therapy for real results. You’ll also learn how psychedelics impact neurohacking, epigenetics, and the default mode network—and why the next frontier of self-transformation may be couples therapy with MDMA. 



This episode offers critical knowledge for anyone serious about biohacking, trauma release, mental performance, and accessing deeper states of healing. This podcast channel dives into the intersections of psychedelics with fastingketosiscold therapy, and self-quantification—and how altered states can unlock more energy, better relationships, and lasting change. 



You’ll Learn: 

• Why separating therapy from psychedelics is the most dangerous path forward 

• How MAPS evolved into a public benefit pharma company—and what went wrong 

• The real story behind the FDA’s rejection of MDMA therapy in 2024 

• How MDMA affects neuroplasticitymitochondria, and trauma recovery 

• Why group therapy and couples therapy are the future of psychedelic healing 

• The dangers of overusing ketamine—and how it’s being exploited by profit-driven clinics 

• What the Psychedelic Science 2025 conference will reveal about the future of medicine, spirituality, and consciousness hacking 

• How psychedelics could reverse epigenetic trauma passed down through generations 

• The role of default mode network suppression in spiritual experiences and trauma resolution 

• Why the war on drugs was never about safety—and what a post-drug-war world might look like 



Dave Asprey is a four-time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade is the top podcast f

Episode description

Psychedelic therapy is on the verge of reshaping mental health, trauma healing, and human consciousness. This episode reveals what’s really happening behind the scenes at the FDA, inside pharmaceutical companies, and within the global movement to legalize MDMA-assisted therapy. 



Watch this episode on YouTube for the full video experience: 

https://www.youtube.com/@DaveAspreyBPR 



Host Dave Asprey sits down with Rick Doblin, PhD, the legendary founder of MAPS and one of the most influential figures in psychedelic science. With nearly 40 years leading clinical research on MDMA, psilocybin, and trauma healing, Rick brings unmatched insight into how these compounds are transforming functional medicine, emotional resilience, and neuroplasticity. 



They break down the regulatory battle over MDMA therapy, the clash between pharmaceutical profit and public benefit, and the urgent need to combine pharmacology with therapy for real results. You’ll also learn how psychedelics impact neurohacking, epigenetics, and the default mode network—and why the next frontier of self-transformation may be couples therapy with MDMA. 



This episode offers critical knowledge for anyone serious about biohacking, trauma release, mental performance, and accessing deeper states of healing. This podcast channel dives into the intersections of psychedelics with fastingketosiscold therapy, and self-quantification—and how altered states can unlock more energy, better relationships, and lasting change. 



You’ll Learn: 

• Why separating therapy from psychedelics is the most dangerous path forward 

• How MAPS evolved into a public benefit pharma company—and what went wrong 

• The real story behind the FDA’s rejection of MDMA therapy in 2024 

• How MDMA affects neuroplasticitymitochondria, and trauma recovery 

• Why group therapy and couples therapy are the future of psychedelic healing 

• The dangers of overusing ketamine—and how it’s being exploited by profit-driven clinics 

• What the Psychedelic Science 2025 conference will reveal about the future of medicine, spirituality, and consciousness hacking 

• How psychedelics could reverse epigenetic trauma passed down through generations 

• The role of default mode network suppression in spiritual experiences and trauma resolution 

• Why the war on drugs was never about safety—and what a post-drug-war world might look like 



Dave Asprey is a four-time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade is the top podcast f

Mindsip insights from this episode:

Recognize drug war as a tool for political suppression

The war on drugs was never truly about drug abuse but was a political tool to suppress minorities and counter-culture movements.

Understand MDMA's impact on PTSD beyond mystical experiences

Unlike classic psychedelics, research shows there is no correlation between the mystical experience on MDMA and the reduction of PTSD symptoms.

Transform epigenetic markers to interrupt multi-generational trauma

Successful therapy can change epigenetic markers, offering the promise of interrupting the transfer of multi-generational trauma from parent to child.

Utilize psychedelics to enhance neuroplasticity in therapy

Research suggests psychedelics open 'critical periods' where the brain is more neuroplastic, making it significantly easier to rewire with therapy.

Recognize ketamine's addictive potential and prioritize integrated therapy

Of all the psychedelics, ketamine has the most addictive potential, making daily use protocols particularly dangerous without integrated therapy.

Choose injectable MDMA for enhanced social experiences

Injectable MDMA can be better for socializing as it comes on and wears off quicker, with less jaw tension and next-day fatigue compared to oral use.

Examine heavy MDMA use for potential neurocognitive benefits

A large NIDA-funded study on 'Fallen Mormons' who only used MDMA heavily found it to be exonerating, with hardly any negative neurocognitive consequences.

Reject drug-only psychedelics to preserve therapeutic integrity

The most dangerous path for the psychedelic movement is the current trend of pharmaceutical companies separating the drug from the therapy to maximize profit.

DOWNLOAD THE APP

Unlock the wisdom of longevity

DOWNLOAD THE APP

Unlock the wisdom of longevity

DOWNLOAD THE APP

Unlock the wisdom of longevity

Unlock the wisdom of longevity

© Mindsip 2025 – Made with ❤ in Vilnius

Unlock the wisdom of longevity

© Mindsip 2025 – Made with ❤ in Vilnius